Matches in Wikidata for { <http://www.wikidata.org/entity/Q64397356> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q64397356 description "clinical trial" @default.
- Q64397356 description "ensayu clínicu" @default.
- Q64397356 description "klinisch onderzoek" @default.
- Q64397356 description "клінічне випробування" @default.
- Q64397356 name "Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)" @default.
- Q64397356 type Item @default.
- Q64397356 label "Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)" @default.
- Q64397356 prefLabel "Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)" @default.
- Q64397356 P1050 Q64397356-BC7D5293-37DB-4ECE-B619-54D8030C7DBB @default.
- Q64397356 P1132 Q64397356-0D6F69B4-A4F5-4301-867E-AFD03D8B71FB @default.
- Q64397356 P1476 Q64397356-CC9F3607-7E4A-48FC-8CF3-1A4AB487F12C @default.
- Q64397356 P2899 Q64397356-A437DAB4-98A4-4B6C-B255-4DE35AB6112B @default.
- Q64397356 P3098 Q64397356-21D1D040-EAEE-4248-8411-168F8D611AC6 @default.
- Q64397356 P31 Q64397356-6D450196-D8C7-4A87-A5F0-EDEC0AF60E65 @default.
- Q64397356 P4844 Q64397356-5F6C52D4-2C05-4D64-83B5-A0632776251D @default.
- Q64397356 P4844 Q64397356-B9DA7A97-CDD5-4DC3-BB6B-EAB9A2C77B1F @default.
- Q64397356 P580 Q64397356-A71D8D1F-A04A-4F52-B94C-97A2C1F6A5A8 @default.
- Q64397356 P582 Q64397356-425AEE30-0D92-4B76-8997-EE2094E7C9E9 @default.
- Q64397356 P6099 Q64397356-BEDAF30D-1EAB-4226-BAA8-5FB0471E02C3 @default.
- Q64397356 P8363 Q64397356-D3CFA97C-E282-4AE9-AD5B-7B11C6E6ED79 @default.
- Q64397356 P1050 Q12206 @default.
- Q64397356 P1132 "+464" @default.
- Q64397356 P1476 "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of Ertugliflozin (MK-8835/PF-04971729) in the Treatment of Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin" @default.
- Q64397356 P2899 "+18" @default.
- Q64397356 P3098 "NCT02036515" @default.
- Q64397356 P31 Q30612 @default.
- Q64397356 P4844 Q19484 @default.
- Q64397356 P4844 Q425027 @default.
- Q64397356 P580 "2014-03-12T00:00:00Z" @default.
- Q64397356 P582 "2016-06-06T00:00:00Z" @default.
- Q64397356 P6099 Q42824827 @default.
- Q64397356 P8363 Q78089383 @default.